Literature DB >> 31883831

Innate immunity as the trigger of systemic autoimmune diseases.

Victoria Saferding1, Stephan Blüml2.   

Abstract

The innate immune system consists of a variety of elements controlling and participating in virtually all aspects of inflammation and immunity. It is crucial for host defense, but on the other hand its improper activation is also thought to be responsible for the generation of autoimmunity and therefore diseases such as autoimmune arthritides like rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), multiple sclerosis (MS) or inflammatory bowel disease. The innate immune system stands both at the beginning as well as the end of autoimmunity. On one hand, it regulates the activation of the adaptive immune system and the breach of self-tolerance, as antigen presenting cells (APCs), especially dendritic cells, are essential for the activation of naïve antigen specific T cells, a crucial step in the development of autoimmunity. Various factors controlling the function of dendritic cells have been identified that directly regulate lymphocyte homeostasis and in some instances the generation of organ specific autoimmunity. Moreover, microbial cues have been identified that are prerequisites for the generation of several specific autoimmune diseases. On the other hand, the innate immune system is also responsible for mediating the resulting organ damage underlying the clinical symptoms of a given autoimmune disease via production of proinflammatory cytokines that amplify local inflammation and further activate other immune or parenchymal cells in the vicinity, the generation of matrix degrading and proteolytic enzymes or reactive oxygen species directly causing tissue damage. In the last decades, molecular characterization of cell types and their subsets as well as both positive and negative regulators of immunity has led to the generation of various scenarios of how autoimmunity develops, which eventually might lead to the development of targeted interventions for autoimmune diseases. In this review, we try to summarize the elements that are contributing to the initiation and perpetuation of autoimmune responses.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Dendritic cells; Innate immunity; Microbiome in autoimmunity; Pattern recognition receptors

Mesh:

Substances:

Year:  2019        PMID: 31883831     DOI: 10.1016/j.jaut.2019.102382

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  19 in total

Review 1.  Redox Activation of Mitochondrial DAMPs and the Metabolic Consequences for Development of Autoimmunity.

Authors:  Andreas Koenig; Iwona A Buskiewicz-Koenig
Journal:  Antioxid Redox Signal       Date:  2022-03       Impact factor: 7.468

2.  Ragweed pollen induces allergic conjunctivitis immune tolerance in mice via regulation of the NF-κB signal pathway.

Authors:  Meng-Tian Bai; Yun Li; Zhu-Lin Hu
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

3.  Effector memory CD4+ T cells induce damaging innate inflammation and autoimmune pathology by engaging CD40 and TNFR on myeloid cells.

Authors:  Margaret M McDaniel; Amanpreet Singh Chawla; Aakanksha Jain; Hannah E Meibers; Irene Saha; Yajing Gao; Viral Jain; Krishna Roskin; Sing Sing Way; Chandrashekhar Pasare
Journal:  Sci Immunol       Date:  2022-01-21

4.  Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase.

Authors:  Zbyšek Pavelek; Francesco Angelucci; Ondřej Souček; Jan Krejsek; Lukáš Sobíšek; Blanka Klímová; Jana Šarláková; Simona Halúsková; Kamil Kuča; Martin Vališ
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

Review 5.  Innate Lymphocytes in Inflammatory Arthritis.

Authors:  Xunyao Wu
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

6.  Effects of targeting the transcription factors Ikaros and Aiolos on B cell activation and differentiation in systemic lupus erythematosus.

Authors:  Felice Rivellese; Sotiria Manou-Stathopoulou; Daniele Mauro; Katriona Goldmann; Debasish Pyne; Ravindra Rajakariar; Patrick Gordon; Peter Schafer; Michele Bombardieri; Costantino Pitzalis; Myles J Lewis
Journal:  Lupus Sci Med       Date:  2021-03

Review 7.  Revisiting B cell tolerance and autoantibodies in seropositive and seronegative autoimmune rheumatic disease (AIRD).

Authors:  J N Pouw; E F A Leijten; J M van Laar; M Boes
Journal:  Clin Exp Immunol       Date:  2020-11-15       Impact factor: 4.330

Review 8.  Innate immunity drives pathogenesis of rheumatoid arthritis.

Authors:  Maria I Edilova; Ali Akram; Ali A Abdul-Sater
Journal:  Biomed J       Date:  2020-07-08       Impact factor: 4.910

9.  An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus.

Authors:  Vitor Cavalcanti Trindade; Magda Carneiro-Sampaio; Eloisa Bonfa; Clovis Artur Silva
Journal:  Paediatr Drugs       Date:  2021-07-10       Impact factor: 3.022

10.  Retrofractamide C Derived from Piper longum Alleviates Xylene-Induced Mouse Ear Edema and Inhibits Phosphorylation of ERK and NF-κB in LPS-Induced J774A.1.

Authors:  Hyung Jin Lim; Seon Gyeong Bak; Eun Jae Park; Sae-Kwang Ku; Soyoung Lee; Seung Woong Lee; Kang Min Lee; Seung-Jae Lee; Mun-Chual Rho
Journal:  Molecules       Date:  2020-09-05       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.